CAH Cardinal Health, Inc. Common Stock
Über Cardinal Health, Inc. Common Stock Unternehmensübersicht von Wikipedia
Cardinal Health ist ein Pharmazieunternehmen in den Vereinigten Staaten mit Firmensitz in Dublin, Ohio und international tätig. Das Unternehmen ist im Finanzindex S&P 500 gelistet. Cardinal Health gehört neben dem Unternehmen McKesson zu den größten Pharmazieunternehmen in den Vereinigten Staaten.
Mehr lesen
Cardinal Health ist ein Pharmazieunternehmen in den Vereinigten Staaten mit Firmensitz in Dublin, Ohio und international tätig. Das Unternehmen ist im Finanzindex S&P 500 gelistet. Cardinal Health gehört neben dem Unternehmen McKesson zu den größten Pharmazieunternehmen in den Vereinigten Staaten.
Das Unternehmen wurde 1971 unter dem Firmennamen Cardinal Foods in Columbus, Ohio, durch Robert D. Walter als Lebensmittelgroßhandel gegründet. 1979 erwarb das Unternehmen das Pharmazieunternehmen Bailey Drug Company und verkaufte Medikamente unter dem Firmennamen Cardinal Distribution, Incorporated. Cardinal Health verkauft neben Medikamenten auch medizinische Geräte und stattet Krankenhäuser, Arztpraxen und Gesundheitszentren entsprechend der Produktpalette aus.
Cardinal Health beschäftigt über 49.500 Mitarbeiter (2019) in 26 Ländern und 350 Standorten weltweit.
## Strafzahlungen
Im seit Jahren andauernden Rechtsstreit um süchtig machende Schmerzmittel haben neben Johnson & Johnson die Arzneimittelgroßhändler McKesson, AmerisourceBergen und Cardinal Health einen milliardenschweren Vergleich mit zahlreichen Klägern akzeptiert. Die Arzneimittelgroßhändler McKesson, AmerisourceBergen und Cardinal Health sowie Johnson & Johnson könnten dabei letztlich bis zu 26 Milliarden Dollar zahlen, wie New Yorks Generalstaatsanwältin Letitia James und Generalstaatsanwälte aus etlichen anderen US-Bundesstaaten im Juli 2021 verkündeten.
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
CAH Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
CAH Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
| Ex-Datum | Betrag |
|---|---|
| 1. Juli 2026 | $0,5160 |
| 1. April 2026 | $0,5110 |
| 2. Januar 2026 | $0,5110 |
| 1. Oktober 2025 | $0,5110 |
| 1. Juli 2025 | $0,5110 |
| 1. April 2025 | $0,5060 |
| 2. Januar 2025 | $0,5060 |
| 1. Oktober 2024 | $0,5060 |
| 1. Juli 2024 | $0,5060 |
| 28. März 2024 | $0,5010 |
| 29. Dezember 2023 | $0,5010 |
| 2. Oktober 2023 | $0,5010 |
| 30. Juni 2023 | $0,5010 |
| 31. März 2023 | $0,4960 |
| 30. Dezember 2022 | $0,4960 |
| 30. September 2022 | $0,4960 |
| 30. Juni 2022 | $0,4960 |
| 31. März 2022 | $0,4910 |
| 31. Dezember 2021 | $0,4910 |
| 30. September 2021 | $0,4910 |
CAH Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
- Starker Kauf 8 34,8%
- Kauf 12 52,2%
- Halten 3 13,0%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
15 Analysten · 2026-08-14Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. Dezember 2026 | $2.91 | $2.44 | 0.47% |
| 30. Juni 2026 | $2.91 | $2.44 | 0.47% |
| 31. März 2026 | $3.17 | $2.82 | 0.35% |
| 31. Dezember 2025 | $2.63 | $2.40 | 0.23% |
| 30. September 2025 | $2.55 | $2.20 | 0.35% |
| 30. Juni 2025 | $2.08 | $2.06 | 0.02% |
| 31. März 2025 | $2.35 | $2.19 | 0.16% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CAH | — | 32.9 | 14.2% | 0.67% | -60.5% | 3.8% |
| MCK | $242.30B | 22.5 | 12.4% | 1.2% | -224.3% | 3.6% |
| COR | $60.61B | 39.3 | 9.3% | 0.48% | 144.3% | 3.6% |
| HSIC | $8.81B | 23.3 | 4.0% | 3.0% | 12.0% | 31.1% |
| AHCO | $1.35B | -19.2 | -0.49% | -2.2% | -4.6% | — |
| ACH | — | — | — | — | — | — |
| MEDS | — | — | — | — | — | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $254.25B | $222.58B | $226.83B | $204.98B | $181.33B | $162.47B | $152.92B | $145.53B | $136.81B | $129.98B | $121.55B | $102.53B | |
| Cost of Revenue | $244.47B | $214.41B | $219.41B | $198.10B | $174.84B | $155.69B | $146.05B | $138.70B | $129.63B | $123.43B | $115.00B | $96.82B | |
| Gross Profit | $9.77B | $8.17B | $7.41B | $6.87B | $6.48B | $6.78B | $6.87B | $6.83B | $7.18B | $6.54B | $6.54B | $5.71B | |
| SG&A Expense | $6.13B | $5.38B | $5.00B | $4.80B | $4.51B | $4.53B | $4.57B | $4.48B | $4.60B | $3.77B | $3.65B | $3.24B | |
| Operating Income | $2.61B | $2.27B | $1.24B | $752M | $-607M | $472M | $-4.10B | $2.06B | $126M | $2.12B | $2.46B | $2.16B | |
| Interest Expense | $348M | $215M | $51M | $84M | $147M | $180M | $238M | $294M | $329M | $201M | $178M | $141M | |
| Other Non-op | $31M | $41M | $9M | $-5M | $-22M | $47M | $1M | $-15M | $-23M | $5M | $-5M | $7M | |
| Pretax Income | $2.17B | $2.10B | $1.20B | $663M | $-784M | $323M | $-3.77B | $1.75B | $-228M | $1.92B | $2.28B | $1.97B | |
| Income Tax | $469M | $532M | $348M | $332M | $153M | $-289M | $-79M | $386M | $-487M | $630M | $845M | $755M | |
| Net Income | $1.71B | $1.56B | $852M | $330M | $-938M | $611M | $-3.70B | $1.36B | $256M | $1.29B | $1.43B | $1.22B | |
| EPS (Basic) | $7.27 | $6.48 | $3.48 | $1.27 | $-3.37 | $2.09 | $-12.61 | $4.55 | $0.82 | $4.06 | $4.36 | $3.66 | |
| EPS (Diluted) | $7.23 | $6.45 | $3.45 | $1.26 | $-3.37 | $2.08 | $-12.61 | $4.53 | $0.81 | $4.03 | $4.32 | $3.62 | |
| Shares (Basic) | 236,000,000 | 241,000,000 | 245,000,000 | 261,000,000 | 279,000,000 | 292,000,000 | 293,000,000 | 300,000,000 | 313,000,000 | 317,000,000 | 327,000,000 | 332,000,000 | |
| Shares (Diluted) | 237,000,000 | 242,000,000 | 247,000,000 | 262,000,000 | 279,000,000 | 294,000,000 | 293,000,000 | 301,000,000 | 315,000,000 | 320,000,000 | 330,000,000 | 335,000,000 | |
| EBITDA | $3.57B | $3.06B | $1.95B | $1.42B | $96M | $1.25B | $-3.19B | $3.06B | $1.16B | $2.84B | $3.10B | $2.61B |
Bilanz 25
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.86B | $3.87B | $5.13B | $4.08B | $4.72B | $3.41B | $2.77B | $2.53B | $1.76B | $6.88B | $2.36B | $4.62B | |
| Short-term Investments | · | · | $200M | · | · | · | · | · | · | $65M | $113M | $91M | |
| Receivables | $13.81B | $13.24B | $12.08B | $11.11B | $10.56B | $9.10B | $8.26B | $8.45B | $7.80B | $8.05B | $7.41B | $6.52B | |
| Inventory | $17.30B | $16.83B | $14.96B | $16.12B | $15.64B | $14.59B | $13.20B | $12.82B | $12.31B | $11.30B | $10.62B | $9.21B | |
| Other Current Assets | $2.76B | $2.41B | $2.66B | $2.29B | $2.02B | $2.84B | $1.71B | $1.95B | $1.93B | $2.12B | $1.58B | $1.40B | |
| Current Assets | $38.75B | $36.37B | $34.88B | $33.74B | $32.94B | $31.05B | $25.94B | $25.75B | $24.55B | $28.34B | $21.96B | $21.75B | |
| PP&E (Net) | $3.03B | $2.86B | $2.53B | $2.46B | $2.36B | $2.36B | $2.37B | $2.36B | $2.49B | $1.88B | $1.80B | $1.51B | |
| PP&E (Gross) | $7.97B | $7.52B | $6.70B | $6.31B | $5.88B | $5.59B | $5.33B | $5.17B | $5.26B | $4.63B | $4.48B | $4.03B | |
| Accum. Depreciation | $4.93B | $4.66B | $4.17B | $3.85B | $3.52B | $3.23B | $2.96B | $2.81B | $2.77B | $2.75B | $2.68B | $2.53B | |
| Goodwill | $11.44B | $9.69B | $4.72B | $4.61B | $5.86B | $7.99B | $8.36B | $8.38B | $8.32B | $7.22B | $7.17B | $5.07B | |
| Intangibles | $2.19B | $2.49B | $1.73B | $1.47B | $1.77B | $2.10B | $2.92B | $3.43B | $3.91B | $1.99B | $1.99B | $948M | |
| Other Non-current Assets | $1.88B | $1.71B | $1.26B | $1.07B | $953M | $951M | $1.19B | $1.05B | $682M | $681M | $944M | $866M | |
| Total Assets | $57.30B | $53.12B | $45.12B | $43.35B | $43.88B | $44.45B | $40.77B | $40.96B | $39.95B | $40.11B | $34.12B | $30.14B | |
| Accounts Payable | $38.28B | $34.71B | $31.76B | $29.93B | $27.13B | $23.70B | $21.37B | $21.54B | $19.68B | $17.91B | $17.31B | $14.37B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | $855M | $0 | $0 | |
| Current Liabilities | $43.90B | $38.90B | $35.64B | $33.74B | $30.55B | $27.62B | $23.61B | $24.11B | $22.89B | $21.22B | $19.70B | $17.24B | |
| Capital Leases | $861M | $654M | $400M | $375M | $388M | $374M | $341M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | $1.75B | $1.81B | $1.95B | $1.70B | $328M | |
| Total Debt | · | · | · | · | · | · | · | · | · | $855M | $0 | · | |
| Common Stock | $2.89B | $2.96B | $2.92B | $2.75B | $2.81B | $2.81B | $2.79B | $2.76B | $2.73B | $2.70B | $3.01B | $3.00B | |
| Retained Earnings | $2.01B | $783M | $-286M | $-642M | $-280M | $1.21B | $1.17B | $5.43B | $4.64B | $4.97B | $6.42B | $5.52B | |
| Treasury Stock | $7.61B | $6.37B | $5.68B | $4.91B | $3.13B | $2.19B | $2.07B | $1.79B | $1.22B | $731M | $2.76B | $2.25B | |
| AOCI | $-165M | $-155M | $-167M | $-151M | $-114M | $-34M | $-104M | $-79M | $-92M | $-125M | $-116M | $-23M | |
| Stockholders' Equity | $-2.88B | $-2.78B | $-3.21B | $-2.96B | $-709M | $1.79B | $1.79B | $6.33B | $6.06B | $6.81B | $6.55B | $6.26B | |
| Liabilities + Equity | $57.30B | $53.12B | $45.12B | $43.35B | $43.88B | $44.45B | $40.77B | $40.96B | $39.95B | $40.11B | $34.12B | $30.14B |
Cashflow 19
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $956M | $790M | $710M | $692M | $692M | $783M | $913M | $1.00B | $1.03B | $717M | $641M | $451M | |
| Stock-based Comp | $367M | $244M | $121M | $96M | $81M | $89M | $90M | $82M | $85M | $96M | $111M | $110M | |
| Deferred Tax | $91M | $243M | $-104M | $-40M | $14M | $496M | $-961M | $-83M | $-1.01B | $291M | $87M | $219M | |
| Amort. of Intangibles | $361M | $303M | $264M | $281M | $311M | $428M | $512M | $531M | $574M | $395M | $355M | $191M | |
| Restructuring | $106M | $88M | $175M | $95M | $101M | $114M | $122M | $125M | $176M | $56M | $25M | $44M | |
| Other Non-cash | $2.05B | $-441M | $2.18B | $1.82B | $3.27B | $450M | $5.61B | $360M | $2.41B | · | $705M | $545M | |
| Operating Cash Flow | $5.17B | $2.40B | $3.76B | $2.84B | $3.17B | $2.43B | $1.96B | $2.72B | $2.77B | $1.18B | $2.97B | $2.54B | |
| CapEx | $649M | $547M | $511M | $481M | $387M | $400M | $375M | $328M | $384M | $387M | $465M | $300M | |
| Investing Cash Flow | $-2.58B | $-5.59B | $-1.85B | $-454M | $567M | $-378M | $493M | $338M | $-5.61B | $-405M | $-4.08B | $-849M | |
| Debt Issued | $1.00B | $2.90B | $1.14B | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $347M | $2.46B | $357M | $-579M | $-885M | $-570M | $-1.40B | $-1.10B | $-954M | $-310M | $-6M | $-1.22B | |
| Stock Repurchased | $1.36B | $765M | $750M | $2.00B | $1.00B | $200M | $350M | $600M | $550M | $600M | $651M | $1.04B | |
| Net Stock Activity | $-1.36B | $-765M | $-750M | $-2.00B | $-1.00B | $-200M | $-350M | $-600M | $-550M | $-600M | $-651M | $-1.04B | |
| Dividends Paid | $491M | $494M | $499M | $525M | $559M | $573M | $569M | $577M | $581M | $577M | $512M | $460M | |
| Financing Cash Flow | $-1.60B | $1.94B | $-847M | $-3.05B | $-2.46B | $-1.32B | $-2.20B | $-2.29B | $-2.28B | $3.75B | $-1.14B | $60M | |
| Net Change in Cash | $982M | $-1.26B | $1.06B | $-669M | $1.36B | $636M | $240M | $768M | $-5.12B | $4.52B | $-2.26B | $1.75B | |
| Taxes Paid | $338M | $444M | $191M | $156M | $-766M | $273M | $368M | $311M | $425M | $686M | $635M | $529M | |
| Free Cash Flow | $4.53B | $1.85B | $3.25B | $2.36B | $2.73B | $2.03B | $1.58B | $2.39B | $2.38B | $797M | $2.51B | $2.24B | |
| Levered FCF | $4.25B | $1.69B | $3.21B | $2.32B | $2.55B | $1.69B | $1.35B | $2.16B | $2.76B | $662M | $2.39B | $2.15B |
Rentabilität 8
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 3.8% | 3.7% | 3.3% | 3.4% | 3.6% | 4.2% | 4.5% | 4.7% | 5.2% | 5.0% | 5.4% | 5.6% | |
| Operating Margin | 1.0% | 1.0% | 0.55% | 0.35% | -0.33% | 0.29% | -2.7% | 1.4% | 0.09% | 1.6% | 2.0% | 2.1% | |
| Net Margin | 0.67% | 0.70% | 0.38% | 0.13% | -0.51% | 0.38% | -2.4% | 0.94% | 0.19% | · | 1.2% | 1.2% | |
| Pretax Margin | 0.86% | 0.94% | 0.53% | 0.31% | -0.42% | 0.20% | -2.5% | 1.2% | -0.17% | 1.5% | 1.9% | 1.9% | |
| EBITDA Margin | 1.4% | 1.4% | 0.86% | 0.69% | 0.05% | 0.77% | -2.1% | 2.1% | 0.85% | 2.2% | 2.5% | 2.5% | |
| ROA | 3.1% | 3.2% | 1.9% | 0.60% | -2.1% | 1.4% | -9.0% | 3.4% | 0.64% | · | 4.4% | 4.3% | |
| ROE | -60.5% | -52.1% | -27.6% | -14.7% | -172.5% | 34.1% | -91.1% | 22.0% | 4.0% | · | 22.3% | 19.2% | |
| ROIC | -71.1% | -61.1% | -27.5% | -10.5% | 101.9% | 49.9% | -224.3% | 25.4% | -2.4% | 18.6% | 23.6% | 21.3% |
Liquidität & Solvenz 4
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 1.0 | 1.0 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.3 | 1.1 | 1.3 | |
| Quick Ratio | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.7 | 0.5 | 0.7 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | 0.1 | 0.0 | · | |
| Interest Coverage | 7.5 | 10.6 | 24.4 | 7.8 | -4.0 | 2.6 | -17.2 | 7.0 | 0.4 | 10.5 | 13.8 | 15.3 |
Effizienz 3
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 4.6 | 4.5 | 5.1 | 4.7 | 4.1 | 3.8 | 3.7 | 3.6 | 3.4 | 3.5 | 3.8 | 3.7 | |
| Inventory Turnover | 14.3 | 13.5 | 14.1 | 12.5 | 11.6 | 11.2 | 11.2 | 11.0 | 11.0 | 11.3 | 11.6 | 11.1 | |
| Receivables Turnover | 18.8 | 17.6 | 19.6 | 18.7 | 18.4 | 18.7 | 18.3 | 17.9 | 17.3 | 16.8 | 17.5 | 17.2 |
Wachstumsraten 10
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 14.2% | -1.9% | 10.7% | 13.0% | 11.6% | 6.2% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.4% | 7.1% | 11.8% | 10.3% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 9.4% | 7.8% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 12.1% | 87.0% | 173.8% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 79.0% | · | 18.4% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 28.3% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 9.8% | 83.2% | 158.2% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 73.2% | · | 11.7% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 22.9% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | -3.0% | -2.8% | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 6
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $254.25B | $222.58B | $226.83B | $204.98B | $181.33B | $162.47B | $152.92B | $145.53B | $136.81B | $129.98B | $121.55B | $102.53B | |
| Net Income TTM | $1.71B | $1.56B | $852M | $330M | $-938M | $611M | $-3.70B | $1.36B | $256M | $1.29B | $1.43B | $1.22B | |
| P/E | 32.9 | 26.0 | 28.5 | 75.1 | -15.5 | 27.4 | -4.1 | 10.4 | 60.3 | 19.3 | 18.1 | 23.1 | |
| Earnings Yield | 3.0% | 3.8% | 3.5% | 1.3% | -6.5% | 3.6% | -24.2% | 9.6% | 1.7% | 5.2% | 5.5% | 4.3% | |
| Payout Ratio | 28.6% | 31.6% | 58.6% | 201.1% | -59.9% | 93.8% | -15.4% | 42.3% | 226.9% | · | 35.9% | 37.9% | |
| Annual Payout | $491M | $494M | $499M | $525M | $559M | $573M | $569M | $577M | $581M | $577M | $512M | $460M |
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $63.67B | $60.94B | $65.63B | $64.01B | $60.16B | $54.88B | $55.26B | $52.28B | $59.87B | $54.87B | $57.44B | $54.65B | $53.42B | $50.50B | $51.47B | $49.59B | |
| Cost of Revenue | $61.11B | $58.44B | $63.23B | $61.69B | $57.96B | $52.76B | $53.32B | $50.38B | $57.98B | $52.93B | $55.59B | $52.91B | $51.61B | $48.69B | $49.78B | $48.00B | |
| Gross Profit | $2.56B | $2.50B | $2.40B | $2.32B | $2.20B | $2.12B | $1.94B | $1.90B | $1.88B | $1.94B | $1.85B | $1.74B | $1.81B | $1.81B | $1.68B | $1.60B | |
| SG&A Expense | $1.62B | $1.54B | $1.50B | $1.46B | $1.48B | $1.31B | $1.31B | $1.28B | $1.28B | $1.27B | $1.27B | $1.19B | $1.23B | $1.17B | $1.18B | $1.20B | |
| Operating Income | $729M | $509M | $707M | $668M | $428M | $730M | $549M | $568M | $401M | $369M | $505M | $-32M | $162M | $604M | $-86M | $123M | |
| Interest Expense | · | · | $88M | $80M | $74M | $74M | $35M | $32M | $9M | $28M | $3M | $11M | $6M | $26M | $24M | $24M | |
| Other Non-op | $26M | $-16M | $11M | $10M | $30M | $9M | $-3M | $5M | $-1M | $1M | $10M | $-1M | $-10M | $-2M | $6M | $-3M | |
| Pretax Income | $554M | $392M | $630M | $598M | $384M | $665M | $511M | $541M | $391M | $342M | $512M | $-44M | $146M | $576M | $-104M | $96M | |
| Income Tax | $154M | $12M | $159M | $144M | $141M | $157M | $110M | $124M | $158M | $80M | $143M | $-33M | $143M | $209M | $-27M | $-3M | |
| Net Income | $398M | $399M | $467M | $450M | $239M | $506M | $400M | $416M | $235M | $261M | $368M | $-12M | $5M | $365M | $-77M | $98M | |
| EPS (Basic) | · | · | · | $1.89 | · | · | · | $1.71 | · | $1.07 | $1.50 | $-0.05 | · | $1.43 | $-0.30 | $0.36 | |
| EPS (Diluted) | · | · | · | $1.88 | · | · | · | $1.70 | · | $1.07 | $1.50 | $-0.05 | · | $1.41 | $-0.30 | $0.36 | |
| Shares (Basic) | -473,000,000 | 235,000,000 | 236,000,000 | 238,000,000 | -484,000,000 | 240,000,000 | 242,000,000 | 243,000,000 | -492,000,000 | 243,000,000 | 245,000,000 | 249,000,000 | -527,000,000 | 256,000,000 | 261,000,000 | 271,000,000 | |
| Shares (Diluted) | -475,000,000 | 236,000,000 | 237,000,000 | 239,000,000 | -487,000,000 | 241,000,000 | 243,000,000 | 245,000,000 | -493,000,000 | 245,000,000 | 246,000,000 | 249,000,000 | -530,000,000 | 258,000,000 | 261,000,000 | 273,000,000 | |
| EBITDA | · | $757M | $941M | $901M | · | $730M | $549M | $750M | · | $367M | $482M | $158M | · | $572M | $-119M | $308M |
Bilanz 21
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.86B | $3.94B | $2.78B | $4.59B | $3.87B | $3.33B | $3.81B | $2.87B | $5.13B | $3.72B | $4.59B | $3.85B | · | $3.99B | $3.65B | $3.49B | |
| Receivables | $13.81B | $13.65B | $13.66B | $13.77B | $13.24B | $12.67B | $12.37B | $11.78B | $12.08B | $11.57B | $11.79B | $11.27B | · | $10.99B | $11.42B | $11.04B | |
| Inventory | $17.30B | $18.01B | $20.12B | $17.56B | $16.83B | $16.16B | $16.90B | $15.62B | $14.96B | $17.28B | $18.45B | $16.99B | · | $16.62B | $17.26B | $15.89B | |
| Other Current Assets | $2.76B | $2.47B | $2.67B | $2.60B | $2.41B | $2.40B | $2.62B | $2.59B | $2.66B | $3.16B | $2.82B | $2.58B | · | $1.90B | $2.26B | $2.27B | |
| Current Assets | $38.75B | $38.06B | $39.23B | $38.54B | $36.37B | $34.59B | $35.76B | $32.91B | $34.88B | $35.73B | $37.66B | $34.69B | · | $33.50B | $34.60B | $32.70B | |
| PP&E (Net) | $3.03B | $2.93B | $2.88B | $2.83B | $2.86B | $2.66B | $2.56B | $2.54B | $2.53B | $2.47B | $2.45B | $2.44B | · | $2.36B | $2.34B | $2.34B | |
| PP&E (Gross) | $7.97B | · | · | · | $7.52B | · | · | · | $6.70B | · | · | · | · | · | · | · | |
| Accum. Depreciation | $4.93B | · | · | · | $4.66B | · | · | · | $4.17B | · | · | · | · | · | · | · | |
| Goodwill | $11.44B | $11.41B | $11.61B | $9.71B | $9.69B | $8.91B | $5.49B | $4.72B | $4.72B | $4.79B | $4.02B | $4.03B | $4.61B | $5.00B | $4.99B | $5.67B | |
| Intangibles | $2.19B | $2.28B | $2.37B | $2.40B | $2.49B | $2.11B | $1.95B | $1.66B | $1.73B | $1.72B | $1.35B | $1.41B | · | $1.57B | $1.63B | $1.69B | |
| Other Non-current Assets | $1.88B | $2.00B | $2.00B | $1.75B | $1.71B | $1.60B | $1.25B | $1.23B | $1.26B | $1.17B | $1.10B | $1.15B | · | $951M | $927M | $985M | |
| Total Assets | $57.30B | $56.69B | $58.08B | $55.23B | $53.12B | $49.87B | $47.00B | $43.06B | $45.12B | $45.88B | $46.57B | $43.71B | · | $43.38B | $44.48B | $43.39B | |
| Accounts Payable | $38.28B | $37.83B | $39.00B | $36.86B | $34.71B | $32.81B | $31.30B | $30.36B | $31.76B | $32.09B | $34.26B | $31.54B | · | $29.60B | $30.08B | $28.36B | |
| Current Liabilities | $43.90B | $41.99B | $43.31B | $40.27B | $38.90B | $36.66B | $35.22B | $34.68B | $35.64B | $36.31B | $38.29B | $35.06B | · | $32.50B | $33.21B | $31.56B | |
| Capital Leases | $861M | · | · | · | $654M | · | · | · | $400M | · | · | · | · | · | · | · | |
| Common Stock | $2.89B | $2.81B | $2.85B | $2.75B | $2.96B | $2.95B | $2.93B | $2.83B | $2.92B | $2.89B | $2.85B | $2.73B | · | $2.82B | $2.75B | $2.58B | |
| Retained Earnings | $2.01B | $1.73B | $1.46B | $1.12B | $783M | $664M | $283M | $14M | $-286M | $-289M | $-425M | $-654M | · | $-342M | $-560M | $-301M | |
| Treasury Stock | $7.61B | $7.22B | $7.03B | $6.58B | $6.37B | $6.38B | $6.03B | $5.96B | $5.68B | $5.70B | $5.72B | $5.40B | $4.91B | $4.55B | $4.25B | $3.88B | |
| AOCI | $-165M | $-161M | $-153M | $-159M | $-155M | $-176M | $-180M | $-155M | $-167M | $-160M | $-155M | $-165M | · | $-142M | $-146M | $-176M | |
| Stockholders' Equity | $-2.88B | $-2.83B | $-2.88B | $-2.88B | $-2.78B | $-2.95B | $-2.99B | $-3.28B | $-3.21B | $-3.27B | $-3.45B | $-3.49B | · | $-2.22B | $-2.21B | $-1.78B | |
| Liabilities + Equity | $57.30B | $56.69B | $58.08B | $55.23B | $53.12B | $49.87B | $47.00B | $43.06B | $45.12B | $45.88B | $46.57B | $43.71B | · | $43.38B | $44.48B | $43.39B |
Cashflow 17
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $241M | $248M | $234M | $233M | $209M | $207M | $192M | $182M | $186M | $177M | $175M | $172M | $176M | $175M | $170M | $171M | |
| Stock-based Comp | $58M | $129M | $87M | $93M | $153M | $31M | $30M | $30M | $33M | $31M | $28M | $29M | $27M | $21M | $25M | $23M | |
| Amort. of Intangibles | $95M | $95M | $84M | $87M | $89M | $77M | $69M | $68M | $73M | $64M | $63M | $64M | $70M | $69M | $71M | $71M | |
| Restructuring | $40M | $25M | $21M | $20M | $27M | $28M | $9M | $24M | $69M | $53M | $28M | $25M | $33M | $16M | $17M | $29M | |
| Other Non-cash | · | · | · | $197M | · | · | · | $-2.27B | · | · | · | $339M | · | · | · | $-281M | |
| Operating Cash Flow | $1.69B | $1.82B | $686M | $973M | $1.52B | $2.92B | $-396M | $-1.65B | $2.08B | $-54M | $1.16B | $528M | $863M | $1.36B | $597M | $23M | |
| CapEx | $264M | $146M | $131M | $108M | $232M | $126M | $99M | $90M | $193M | $112M | $114M | $92M | $217M | $109M | $85M | $70M | |
| Investing Cash Flow | $-281M | $-181M | $-1.98B | $-142M | $-1.63B | $-2.90B | $-976M | $-88M | $166M | $-1.85B | $-105M | $-63M | $-206M | $-91M | $-87M | $-70M | |
| Debt Issued | $0 | $0 | $0 | $1.00B | $0 | $0 | · | · | $0 | · | · | · | · | · | · | · | |
| Net Debt Issued | · | · | · | $488M | · | · | · | $-9M | · | · | · | $-7M | · | · | · | $-7M | |
| Stock Repurchased | $350M | $250M | $383M | $375M | $0 | $375M | $15M | $375M | $0 | $0 | $250M | $500M | $500M | $250M | $250M | $1.00B | |
| Net Stock Activity | · | · | · | $-375M | · | · | · | $-375M | · | · | · | $-500M | · | · | · | $-1.00B | |
| Dividends Paid | $120M | $120M | $122M | $129M | $120M | $124M | $122M | $128M | $122M | $122M | $124M | $131M | $126M | $128M | $129M | $142M | |
| Financing Cash Flow | $-490M | $-483M | $-519M | $-110M | $663M | $-507M | $2.33B | $-540M | $-859M | $1.03B | $-353M | $-666M | $-592M | $-934M | $-362M | $-1.16B | |
| Net Change in Cash | $919M | $1.16B | $-1.82B | $719M | $548M | $-484M | $943M | $-2.27B | $1.39B | $-878M | $710M | $-206M | $58M | $336M | $162M | $-1.23B | |
| Free Cash Flow | · | · | · | $865M | · | · | · | $-1.74B | · | · | · | $453M | · | · | · | $-47M | |
| Levered FCF | · | · | · | $804M | · | · | · | $-1.76B | · | · | · | $456M | · | · | · | $-72M |
Rentabilität 8
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 4.1% | 3.6% | 3.6% | · | 3.9% | 3.5% | 3.6% | · | 3.5% | 3.2% | 3.2% | · | 3.5% | 3.2% | 3.2% | |
| Operating Margin | · | 0.84% | 1.1% | 1.0% | · | 1.3% | 0.99% | 1.1% | · | 0.67% | 0.84% | -0.03% | · | 1.1% | -0.23% | 0.28% | |
| Net Margin | · | 0.65% | 0.71% | 0.70% | · | 0.92% | 0.72% | 0.80% | · | 0.47% | 0.61% | 0.01% | · | 0.68% | -0.25% | 0.22% | |
| Pretax Margin | · | 0.64% | 0.96% | 0.93% | · | 1.2% | 0.92% | 1.0% | · | 0.62% | 0.85% | -0.05% | · | 1.1% | -0.27% | 0.22% | |
| EBITDA Margin | · | 1.2% | 1.4% | 1.4% | · | 1.3% | 0.99% | 1.4% | · | 0.67% | 0.84% | 0.29% | · | 1.1% | -0.23% | 0.62% | |
| ROA | · | 0.75% | 0.89% | 0.92% | · | 1.1% | 0.85% | 0.96% | · | 0.58% | 0.78% | 0.01% | · | 0.81% | -0.29% | 0.25% | |
| ROE | · | -13.8% | -15.9% | -14.6% | · | -16.3% | -12.4% | -12.3% | · | -9.4% | -12.5% | -0.19% | · | -23.6% | 21.4% | -56.7% | |
| ROIC | · | -17.4% | -18.3% | -17.6% | · | -18.9% | -14.4% | -13.4% | · | -8.5% | -10.1% | -0.09% | · | -16.4% | 5.1% | -7.8% |
Liquidität & Solvenz 3
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 0.9 | 0.9 | 1.0 | · | 0.9 | 1.0 | 0.9 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.0 | 1.0 | |
| Quick Ratio | · | 0.4 | 0.4 | 0.5 | · | 0.4 | 0.5 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | |
| Interest Coverage | · | · | 8.0 | 8.3 | · | 9.9 | 15.7 | 17.8 | · | 11.1 | 60.2 | -1.0 | · | 20.4 | -4.8 | 5.5 |
Effizienz 3
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 1.1 | 1.2 | 1.3 | · | 1.1 | 1.2 | 1.2 | · | 1.2 | 1.3 | 1.3 | · | 1.2 | 1.2 | 1.1 | |
| Inventory Turnover | · | 3.4 | 3.4 | 3.7 | · | 3.2 | 3.0 | 3.1 | · | 3.1 | 3.1 | 3.2 | · | 3.0 | 3.1 | 3.1 | |
| Receivables Turnover | · | 4.6 | 5.0 | 5.0 | · | 4.5 | 4.6 | 4.5 | · | 4.9 | 5.0 | 4.9 | · | 4.8 | 4.9 | 4.9 |
Bewertung (TTM) 5
| Kennzahl | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $245.45B | $239.78B | $226.43B | · | $217.29B | $219.85B | $219.24B | · | $217.46B | $214.06B | $206.21B | · | $196.39B | $191.35B | $183.85B | |
| Net Income TTM | · | $1.82B | $1.82B | $1.77B | · | $1.58B | $1.45B | $1.03B | · | $982M | $644M | $374M | · | $-1.00B | $-1.32B | $-973M | |
| P/E | · | · | · | · | · | 32.6 | 28.0 | 26.2 | · | 28.5 | 39.4 | 61.1 | · | · | · | · | |
| Earnings Yield | · | · | · | · | · | 3.1% | 3.6% | 3.8% | · | 3.5% | 2.5% | 1.6% | · | · | · | · | |
| Payout Ratio | · | · | · | 28.7% | · | · | · | 30.8% | · | · | · | 2620.0% | · | · | · | 129.1% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | |
|---|---|---|---|---|---|
| Umsatz | $254.25B | $222.58B | $226.83B | $204.98B | $181.33B |
| Bruttogewinnmarge % | 3.8% | 3.7% | 3.3% | 3.4% | 3.6% |
| Betriebsgewinnmarge % | 1.0% | 1.0% | 0.55% | 0.35% | -0.33% |
| Nettoergebnis | $1.71B | $1.56B | $852M | $330M | $-938M |
| Verwässerte EPS | $7.23 | $6.45 | $3.45 | $1.26 | $-3.37 |
Bilanz
| 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 0.9 | 0.9 | 1.0 | 1.0 | 1.1 |
| Quick Ratio | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 |
Cashflow
| 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | |
|---|---|---|---|---|---|
| Freier Cashflow | $4.53B | $1.85B | $3.25B | $2.36B | $2.73B |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 1.618 Einreicher · $31.0B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 162 (-12 vs. Vorquartal) | 80 (-20 vs. Vorquartal) | 516 (-30 vs. Vorquartal) | 545 (+38 vs. Vorquartal) | +35.4M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $3.632.811.706 | 15.292.186 | 11,74% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3.258.822.899 | 13.717.894 | 10,53% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $3.254.296.668 | 13.698.841 | 10,51% | Aktien |
| STATE STREET CORP | $2.842.909.265 | 11.967.121 | 9,18% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $1.350.305.229 | 5.709.017 | 4,36% | Aktien |
| WCM INVESTMENT MANAGEMENT, LLC | $971.445.537 | 4.112.461 | 3,14% | Aktien |
| NORGES BANK | $885.248.810 | 3.726.422 | 2,86% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $499.624.076 | 2.103.149 | 1,61% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $469.793.667 | 1.977.579 | 1,52% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $315.702.986 | 1.328.940 | 1,02% | Aktien |
| VANGUARD GROUP INC | $277.003.725 | 1.347.950 | 0,89% | Aktien |
| Robeco Institutional Asset Management B.V. | $258.918.781 | 1.089.909 | 0,84% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $244.584.818 | 1.029.571 | 0,79% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $230.523.823 | 970.390 | 0,74% | Aktien |
| BlackRock, Inc. | $225.912.433 | 950.970 | 0,73% | Aktien |
| Man Group plc | $220.862.620 | 929.713 | 0,71% | Aktien |
| FMR LLC | $211.855.495 | 891.798 | 0,68% | Aktien |
| GOLDMAN SACHS GROUP INC | $199.229.035 | 838.647 | 0,64% | Aktien |
| ProShare Advisors LLC | $197.187.154 | 830.052 | 0,64% | Aktien |
| NORDEA INVESTMENT MANAGEMENT AB | $192.568.890 | 809.283 | 0,62% | Aktien |
| Legal & General Group Plc | $184.918.605 | 778.408 | 0,60% | Aktien |
| JANE STREET GROUP, LLC | $169.712.864 | 714.400 | 0,55% | Kaufoption |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $160.043.538 | 677.519 | 0,52% | Aktien |
| Swiss National Bank | $157.644.816 | 663.600 | 0,51% | Aktien |
| JANE STREET GROUP, LLC | $153.701.320 | 647.000 | 0,50% | Verkaufsoption |
| Mitsubishi UFJ Asset Management Co., Ltd. | $141.722.832 | 596.577 | 0,46% | Aktien |
| 1832 Asset Management L.P. | $139.039.117 | 585.280 | 0,45% | Aktien |
| Sumitomo Mitsui Trust Group, Inc. | $132.703.867 | 558.612 | 0,43% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $130.681.756 | 550.100 | 0,42% | Aktien |
| BANK OF AMERICA CORP /DE/ | $126.454.568 | 532.306 | 0,41% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $123.081.499 | 518.107 | 0,40% | Aktien |
| Vanguard Global Advisers, LLC | $122.136.010 | 514.127 | 0,39% | Aktien |
| LPL Financial LLC | $120.559.117 | 507.489 | 0,39% | Aktien |
| RHUMBLINE ADVISERS | $116.899.342 | 492.084 | 0,38% | Aktien |
| UBS Group AG | $116.739.360 | 491.410 | 0,38% | Aktien |
| National Pension Service | $113.432.762 | 477.491 | 0,37% | Aktien |
| FRED ALGER MANAGEMENT, LLC | $111.665.316 | 470.051 | 0,36% | Aktien |
| SEI INVESTMENTS CO | $110.593.700 | 465.540 | 0,36% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $109.533.215 | 461.076 | 0,35% | Aktien |
| BARCLAYS PLC | $108.067.946 | 454.908 | 0,35% | Aktien |
| LAZARD ASSET MANAGEMENT LLC | $106.528.318 | 448.427 | 0,34% | Aktien |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $104.481.026 | 439.809 | 0,34% | Aktien |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $104.081.450 | 438.127 | 0,34% | Aktien |
| California Public Employees Retirement System | $103.583.999 | 436.033 | 0,33% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $101.984.508 | 429.300 | 0,33% | Kaufoption |
| TWO SIGMA ADVISERS, LP | $96.441.150 | 469.300 | 0,31% | Aktien |
| JANUS HENDERSON GROUP PLC | $96.030.102 | 454.526 | 0,31% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $95.040.000 | 400.069 | 0,31% | Aktien |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $94.526.074 | 397.904 | 0,31% | Aktien |
| ING GROEP NV | $90.805.885 | 382.244 | 0,29% | Aktien |
| Retirement Systems of Alabama | $89.453.931 | 376.553 | 0,29% | Aktien |
| BANK OF NOVA SCOTIA | $88.870.008 | 374.095 | 0,29% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $88.654.749 | 373.189 | 0,29% | Aktien |
| Artemis Investment Management LLP | $87.745.162 | 369.360 | 0,28% | Aktien |
| TD Asset Management Inc | $85.393.555 | 359.461 | 0,28% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $85.236.528 | 358.800 | 0,28% | Verkaufsoption |
| Delta Accumulation, LLC | $81.886.932 | 344.700 | 0,26% | Verkaufsoption |
| STOREBRAND ASSET MANAGEMENT AS | $80.500.769 | 338.865 | 0,26% | Aktien |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $79.269.258 | 333.681 | 0,26% | Aktien |
| ROYAL BANK OF CANADA | $79.026.000 | 332.656 | 0,26% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $78.334.941 | 370.711 | 0,25% | Aktien |
| Ensign Peak Advisors, Inc | $78.327.333 | 329.716 | 0,25% | Aktien |
| GFS Advisors, LLC | $76.777.103 | 55 | 0,25% | Aktien |
| Integral Health Asset Management, LLC | $71.268.000 | 300.000 | 0,23% | Aktien |
| Focus Partners Wealth | $69.563.786 | 292.826 | 0,22% | Aktien |
| ZACKS INVESTMENT MANAGEMENT | $69.526.717 | 292.669 | 0,22% | Aktien |
| PRUDENTIAL FINANCIAL INC | $69.141.838 | 291.050 | 0,22% | Aktien |
| FIRST TRUST ADVISORS LP | $63.253.014 | 266.262 | 0,20% | Aktien |
| Caisse de depot et placement du Quebec | $63.072.655 | 265.502 | 0,20% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $60.514.609 | 254.734 | 0,20% | Aktien |
| CANADA PENSION PLAN INVESTMENT BOARD | $60.313.158 | 253.886 | 0,19% | Aktien |
| Gotham Asset Management, LLC | $59.744.915 | 251.494 | 0,19% | Aktien |
| NATIXIS | $57.996.711 | 244.135 | 0,19% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $57.683.884 | 243.678 | 0,19% | Aktien |
| AMERIPRISE FINANCIAL INC | $56.823.880 | 239.198 | 0,18% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $56.038.504 | 235.892 | 0,18% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $55.998.840 | 265.008 | 0,18% | Aktien |
| Vest Financial, LLC | $55.494.016 | 233.600 | 0,18% | Aktien |
| AVIVA PLC | $54.653.054 | 230.060 | 0,18% | Aktien |
| COOKSON PEIRCE & CO INC | $54.112.422 | 227.784 | 0,17% | Aktien |
| APG Asset Management N.V. | $52.132.088 | 250.895 | 0,17% | Aktien |
| Delta Accumulation, LLC | $50.101.404 | 210.900 | 0,16% | Kaufoption |
| Quantinno Capital Management LP | $49.716.731 | 209.280 | 0,16% | Aktien |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $48.954.227 | 206.071 | 0,16% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $48.870.606 | 205.719 | 0,16% | Aktien |
| Zurich Insurance Group Ltd/FI | $47.315.063 | 199.171 | 0,15% | Aktien |
| CRAWFORD INVESTMENT COUNSEL INC | $45.812.739 | 192.847 | 0,15% | Aktien |
| Cetera Investment Advisers | $45.437.576 | 191.268 | 0,15% | Aktien |
| Empyrean Capital Partners, LP | $43.758.552 | 184.200 | 0,14% | Aktien |
| Squarepoint Ops LLC | $43.560.427 | 183.366 | 0,14% | Aktien |
| PFA Pension, Forsikringsaktieselskab | $43.480.161 | 183.028 | 0,14% | Aktien |
| Davidson Kempner Capital Management LP | $43.260.389 | 182.103 | 0,14% | Aktien |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $42.795.484 | 180.146 | 0,14% | Aktien |
| Pictet Asset Management Holding SA | $42.685.837 | 179.688 | 0,14% | Aktien |
| OSAIC HOLDINGS, INC. | $41.443.725 | 174.339 | 0,13% | Aktien |
| CHURCHILL MANAGEMENT Corp | $40.806.561 | 242.896 | 0,13% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $40.701.876 | 171.074 | 0,13% | Aktien |
| AMF Tjanstepension AB | $40.543.890 | 170.668 | 0,13% | Aktien |
| Voleon Capital Management LP | $40.128.160 | 168.918 | 0,13% | Aktien |
| CITADEL ADVISORS LLC | $40.028.860 | 168.500 | 0,13% | Kaufoption |
Unternehmensinsider 85 Insider · 45 Führungskräfte · 37 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Deborah Weitzman | CEO, PSS Segment | 15. August 2026 F | 85.255 | 0 | 1 | $-3.216.375 |
| Stephen M Mason | CEO, GMPD Segment | 15. August 2026 F | 53.061 | 0 | 3 | $-6.187.063 |
| Jason M. Hollar | Chief Executive Officer | 15. August 2026 F | 315.132 | 0 | 5 | $-21.424.216 |
| Michael C Kaufmann | CEO | 15. August 2022 M | 601.065 | 0 | 0 | $0 |
| Victor L. Crawford | CEO, Pharmaceutical Segment | 15. August 2022 F | 105.699 | 0 | 0 | $0 |
| Jon L Giacomin | CEO, Medical Segment | 15. August 2019 F | 61.387 | 0 | 0 | $0 |
| Donald M Casey Jr. | CEO, Medical Segment | 15. September 2017 F | 146.503 | 0 | 0 | $0 |
| Michael A Lynch | CEO, Medical Segment | 27. Februar 2012 M | 89.204 | 0 | 0 | $0 |
| Kerry R Clark | Former Chairman and CEO | 1. September 2009 A | 238.635 | 0 | 0 | $0 |
| Mark W Parrish | CEO - HSCS | 2. September 2007 F | 68.041 | 0 | 0 | $0 |
| Ronald K Labrum | CEO-Supply Chain Svcs. | 16. Mai 2006 M | 36.082 | 0 | 0 | $0 |
| Joseph C Papa | Chmn & CEO, Pharm Techn & Svcs | 13. Dezember 2004 A | 14.400 | 0 | 0 | $0 |
| Aaron E Alt | Chief Financial Officer | 15. August 2026 F | 62.495 | 0 | 2 | $-7.177.390 |
| Jorge M Gomez | Chief Financial Officer | 8. November 2018 F | 39.582 | 0 | 0 | $0 |
| Jeffrey William Henderson | Chief Financial Officer | 27. August 2014 M | 67.190 | 0 | 0 | $0 |
| Richard J Miller | EVP & CFO | 17. November 2003 A | — | 0 | 0 | $0 |
| George L Fotiades | President & COO | 15. Januar 2003 P | 80.278 | 0 | 0 | $0 |
| Valerie Christine Pitteroff | Chief Human Resources Officer | 15. August 2026 F | 11.757 | 0 | 0 | $0 |
| Mary C. Scherer | Chief Accounting Officer | 15. August 2026 F | 5.113 | 0 | 1 | $-1.009.826 |
| Michelle D. Greene | Chief Information Officer | 15. August 2026 F | 21.980 | 0 | 2 | $-2.009.043 |
| Jessica L Mayer | Chief Legal/Compliance Officer | 15. August 2026 F | 62.512 | 0 | 3 | $-5.666.833 |
| Ola M Snow | Chief Human Resources Officer | 19. August 2025 S | 15.431 | 0 | 2 | $-4.192.917 |
| Patricia M English | Chief Accounting Officer | 15. August 2022 F | 9.000 | 0 | 0 | $0 |
| Brian S Rice | Chief Information Officer | 15. August 2022 F | 37.850 | 0 | 0 | $0 |
| Michele Holcomb | EVP - Strategy & Corp. Dev. | 15. August 2022 F | 44.491 | 0 | 0 | $0 |
| Stuart G Laws | SVP & Chief Accounting Officer | 15. August 2020 F | 12.289 | 0 | 0 | $0 |
| Craig S Morford | Chief Legal/Compliance Officer | 3. Dezember 2018 F | 126.301 | 0 | 0 | $0 |
| Patricia Morrison | Chief Information Officer | 31. August 2018 F | 30.725 | 0 | 0 | $0 |
| Pamela O. Kimmet | Chief Human Resources Officer | 15. August 2018 F | 22.612 | 0 | 0 | $0 |
| George S Barrett | Executive Chairman | 15. August 2018 F | 502.630 | 0 | 0 | $0 |
| Carole S Watkins | Chief HR Officer | 20. Mai 2016 M | 31.585 | 0 | 0 | $0 |
| Falk T Stephen | EVP, Gen. Counsel & Corp. Sec. | 30. November 2015 G | 32.455 | 0 | 0 | $0 |
| Meghan Fitzgerald | EVP, Strategy & Health Policy | 17. November 2015 F | 16.760 | 0 | 0 | $0 |
| Mark R Blake | EVP - Strategy & Corp. Dev. | 7. November 2014 M | 20.409 | 0 | 0 | $0 |
| Ivan K Fong | CLO & Secretary | 1. November 2008 F | 50.886 | 0 | 0 | $0 |
| Vivek Jain | EVP - Corp. Dev. & Strategy | 26. September 2008 A | 39.594 | 0 | 0 | $0 |
| Daniel J Walsh | EVP, Chf Ethcs & Compl Offcr | 26. November 2007 I | 1.740 | 0 | 0 | $0 |
| Eric Slusser | EVP, CAO & Controller | 4. Juni 2007 M | 8.573 | 0 | 0 | $0 |
| Brendan A Ford | EVP-Corporate Development | 2. September 2006 F | 85.978 | 0 | 0 | $0 |
| RUCCI ANTHONY J | EVP & Chief Admin. Officer | 6. September 2005 G | 55.382 | 0 | 0 | $0 |
| Gary D Dolch | EVP - Quality & Reg. Affairs | 2. September 2005 A | 6.137 | 0 | 0 | $0 |
| Jody R Davids | EVP & CIO | 2. September 2005 A | 4.607 | 0 | 0 | $0 |
| Paul S Williams | EVP, CLO & Secretary | 17. Februar 2005 G | 7.000 | 0 | 0 | $0 |
| Gary S Jensen | SVP - Corporate Controller | 23. August 2004 A | 2.462 | 0 | 0 | $0 |
| Stephen S Thomas | EVP-Group Pres.-AIS | 24. Februar 2004 M | 31.039 | 0 | 0 | $0 |
| Hall Patricia Hemingway | Direktor | 15. April 2026 A | 28.645 | 0 | 0 | $0 |
| Christine Mundkur | Direktor | 5. November 2025 A | 7.536 | 0 | 0 | $0 |
| Gregory B Kenny | Direktor | 5. November 2025 A | 64.194 | 0 | 0 | $0 |
| Sudhakar Ramakrishna | Direktor | 15. März 2025 A | 1.049 | 0 | 0 | $0 |
| Michelle Brennan | Direktor | 6. November 2024 A | 7.019 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Cardinal Health, Inc. ×2 Einreichungen | 5. Juni 2014 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 2. Juli 2004 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 28. Mai 2004 | — | Erste Einreichung | M&A / Verkauf | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 224 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| EGGS · Tidal Trust III | 4,07% | 11.627 NS | 31. Mai 2026 | N-PORT |
| BCUS · Exchange Listed Funds Trust | 2,96% | 16.250 NS | 31. Mai 2026 | N-PORT |
| IYK · iShares Trust | 2,53% | 151.717 SH | 8. August 2026 | Täglich |
| POWA · Invesco Exchange-Traded Self-Indexe… | 2,21% | 17.153 SH | 8. August 2026 | Täglich |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,98% | 89.549 NS | 30. April 2026 | N-PORT |
| NUMV · Nushares ETF Trust | 1,83% | 40.961 NS | 30. April 2026 | N-PORT |
| FLOW · Global X Funds | 1,70% | 2.476 NS | 31. Mai 2026 | N-PORT |
| ZECP · Zacks Trust | 1,69% | 29.490 NS | 31. Mai 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,66% | 54.825 SH | 8. August 2026 | Täglich |
| COWZ · Pacer Funds Trust | 1,62% | 1.528.597 NS | 30. April 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 1,62% | 3.926 NS | 30. April 2026 | N-PORT |
| PWV · Invesco Exchange-Traded Fund Trust | 1,56% | 118.283 SH | 8. August 2026 | Täglich |
| NOBL · ProShares Trust | 1,41% | 791.661 NS | 31. Mai 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 1,38% | 796 NS | 30. April 2026 | N-PORT |
| KNG · First Trust Exchange-Traded Fund IV | 1,37% | 239.259 NS | 30. April 2026 | N-PORT |
| VFMV · VANGUARD WELLINGTON FUND | 1,34% | 23.570 SH | 8. August 2026 | Täglich |
| RWL · Invesco Exchange-Traded Fund Trust … | 1,34% | 563.995 SH | 8. August 2026 | Täglich |
| GROZ · Zacks Trust | 1,19% | 5.456 NS | 31. Mai 2026 | N-PORT |
| SRHQ · Elevation Series Trust | 1,09% | 10.932 NS | 30. April 2026 | N-PORT |
| SPVM · Invesco Exchange-Traded Fund Trust | 1,08% | 5.969 SH | 8. August 2026 | Täglich |
| RPV · Invesco Exchange-Traded Fund Trust | 1,08% | 77.480 SH | 8. August 2026 | Täglich |
| ESMV · iShares Trust | 1,06% | 350 SH | 8. August 2026 | Täglich |
| NULV · Nushares ETF Trust | 1,03% | 110.401 NS | 30. April 2026 | N-PORT |
| AMOM · Exchange Listed Funds Trust | 1,00% | 1.584 NS | 30. April 2026 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0,96% | 1.504.470 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,82% | 707.389 SH | 8. August 2026 | Täglich |
| ABFL · Abacus FCF ETF Trust | 0,80% | 20.613 NS | 30. April 2026 | N-PORT |
| ROE · EA Series Trust | 0,79% | 10.387 NS | 29. Mai 2026 | N-PORT |
| VAMO · Cambria ETF Trust | 0,78% | 3.359 NS | 30. April 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,74% | 387 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,74% | 109.528 NS | 30. April 2026 | N-PORT |
| UPSD · ETF Series Solutions | 0,73% | 3.833 NS | 30. April 2026 | N-PORT |
| IWP · iShares Trust | 0,73% | 619.589 SH | 8. August 2026 | Täglich |
| IXJ · iShares Trust | 0,70% | 122.846 SH | 8. August 2026 | Täglich |
| LGDX · Tidal Trust III | 0,69% | 4.947 NS | 30. April 2026 | N-PORT |
| RXL · ProShares Trust | 0,67% | 2.454 NS | 31. Mai 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0,66% | 524 NS | 30. April 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,65% | 4.692 NS | 30. April 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,58% | 38.214 NS | 30. April 2026 | N-PORT |
| QARP · DBX ETF Trust | 0,58% | 2.209 NS | 29. Mai 2026 | N-PORT |
| CLSE · Trust for Professional Managers | 0,58% | 18.083 NS | 31. Mai 2026 | N-PORT |
| FLCV · Federated Hermes ETF Trust | 0,56% | 2.763 NS | 31. Mai 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0,54% | 5.075.476 SH | 8. August 2026 | Täglich |
| QUVU · Hartford Funds Exchange-Traded Trust | 0,52% | 4.667 NS | 30. April 2026 | N-PORT |
| ITAN · EA Series Trust | 0,50% | 2.246 NS | 29. Mai 2026 | N-PORT |
| EVUS · iShares Trust | 0,49% | 7.746 SH | 8. August 2026 | Täglich |
| KRMA · Global X Funds | 0,47% | 2.880 NS | 31. Mai 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,47% | 18.983 SH | 8. August 2026 | Täglich |
| JMID · Janus Detroit Street Trust | 0,45% | 423 NS | 30. April 2026 | N-PORT |
| SFGV · EA Series Trust | 0,42% | 24.321 NS | 29. Mai 2026 | N-PORT |